Boehringer Ingelheim To Present Data At RAS Summit Europe
Last week marked an exciting time for the RAS community with Boehringer Ingelheim advancing the first Pan-KRAS inhibitor into clinical testing.
Don’t miss this unique opportunity to…
Read More...
Read More...